Surrogate endpoint - PDFSEARCH.IO - Document Search Engine

Surrogate endpoint
Results: 164

#	Item
121	Surrogate Endpoints Mark Rothmann* Minimal Residue Disease in CLL Workshop February 27, 2013 The views expressed in this presentation are those of the presenters and do not necessarily represent those of the U.S. Food a Add to Reading List Source URL: www.fda.gov Language: English* Clinical trials Research Medical statistics Medical research Medical terms Surrogate endpoint Clinical endpoint Biomarker Randomized controlled trial Medicine Epidemiology Health
122	Predicting/Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products February 27, 2013 Add to Reading List Source URL: www.fda.gov Language: English Research Viral load Surrogate endpoint HIV FDA Fast Track Development Program Clinical endpoint Food and Drug Administration Imaging biomarker Discovery and development of integrase inhibitors Medicine HIV/AIDS Health
123	Minimal Residual Disease (MRD) as a Surrogate Endpoint in Chronic Lymphocytic Leukemia (CLL) Workshop R. Angelo de Claro, M.D., William Wierda, M.D., Ph.D., and Gregory Reaman, M.D., Co-Chairs Add to Reading List Source URL: www.fda.gov Language: English Doctoral degrees Doctor of Medicine Higher education Minimal residual disease Education Academia Knowledge
124	Transcript: Public Workshop on Minimal Residual Disease (MRD) as a Surrogate Endpoint in Chronic Lymphocytic Leukemia (CLL) Add to Reading List Source URL: www.fda.gov Language: English Clinical trials Epidemiology Medical research Medical terms FDA Fast Track Development Program Surrogate endpoint Minimal residual disease B-cell chronic lymphocytic leukemia Center for Devices and Radiological Health Medicine Health Food and Drug Administration
125	Statistical Considerations for Surrogate Endpoints Mark Rothmann* Minimal Residue Disease in AML Workshop March 4, 2013 The views expressed in this presentation are those of the presenters and Add to Reading List Source URL: www.fda.gov Language: English* Health Clinical trials Clinical research Medical research Medical terms Surrogate endpoint Clinical endpoint Biomarker Randomized controlled trial Medicine Biology Epidemiology
126	[removed]Federal Register / Vol. 77, No[removed]Wednesday, December 26, [removed]Notices The Food and Drug Administration (FDA) is correcting a Add to Reading List Source URL: www.gpo.gov Language: English - Date: 2012-12-22 11:14:57 Epidemiology Medical research Medical terms Pharmacology Surrogate endpoint Biomarker Food and Drug Administration Acute myeloid leukemia Minimal residual disease Medicine Health Clinical trials
127	Companion Diagnostic Guidance Add to Reading List Source URL: www.fda.gov Language: English Epidemiology Medical research Pharmacology Clinical trials Medical terms Surrogate endpoint Biomarker Minimal residual disease Imaging biomarker Medicine Health Research
128	Companion Diagnostic Guidance Add to Reading List Source URL: www.fda.gov Language: English Epidemiology Medical research Pharmacology Clinical trials Medical terms Surrogate endpoint Biomarker Minimal residual disease Imaging biomarker Medicine Health Research
129	Predicting/Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products March 4, 2013 Add to Reading List Source URL: www.fda.gov Language: English Research Viral load Surrogate endpoint HIV FDA Fast Track Development Program Clinical endpoint Food and Drug Administration Imaging biomarker Discovery and development of integrase inhibitors Medicine HIV/AIDS Health
130	Minimal Residual Disease (MRD) as a Surrogate Endpoint in Chronic Lymphocytic Leukemia (CLL) Workshop DISCUSSION POINTS Add to Reading List Source URL: www.fda.gov

UPDATE